These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 20880116

  • 21. RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome.
    Chen CY, Lin LI, Tang JL, Ko BS, Tsay W, Chou WC, Yao M, Wu SJ, Tseng MH, Tien HF.
    Br J Haematol; 2007 Nov; 139(3):405-14. PubMed ID: 17910630
    [Abstract] [Full Text] [Related]

  • 22. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
    Hu Z, Hu S, Ji C, Tang Z, Thakral B, Loghavi S, Medeiros LJ, Wang W.
    Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
    [Abstract] [Full Text] [Related]

  • 23. [Myeloproliferative/myelodysplastic syndromes].
    Solary E, Fontenay M.
    Rev Prat; 2010 Dec 20; 60(10):1413-5. PubMed ID: 21425542
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Kuo MC, Tang TC.
    Clin Cancer Res; 2005 Mar 01; 11(5):1821-6. PubMed ID: 15756005
    [Abstract] [Full Text] [Related]

  • 27. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
    Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu B.
    Clin Transl Oncol; 2021 Sep 01; 23(9):1731-1742. PubMed ID: 33861431
    [Abstract] [Full Text] [Related]

  • 28. [Role of ASXL1 mutation in myeloid malignancies].
    Sheng MY, Zhou Y, Xu MJ, Yang FC.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug 01; 22(4):1183-7. PubMed ID: 25130853
    [Abstract] [Full Text] [Related]

  • 29. Age-related mutations and chronic myelomonocytic leukemia.
    Mason CC, Khorashad JS, Tantravahi SK, Kelley TW, Zabriskie MS, Yan D, Pomicter AD, Reynolds KR, Eiring AM, Kronenberg Z, Sherman RL, Tyner JW, Dalley BK, Dao KH, Yandell M, Druker BJ, Gotlib J, O'Hare T, Deininger MW.
    Leukemia; 2016 Apr 01; 30(4):906-13. PubMed ID: 26648538
    [Abstract] [Full Text] [Related]

  • 30. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
    Shih LY, Lin TL, Wang PN, Wu JH, Dunn P, Kuo MC, Huang CF.
    Cancer; 2004 Sep 01; 101(5):989-98. PubMed ID: 15329908
    [Abstract] [Full Text] [Related]

  • 31. RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia.
    Bera R, Chiu MC, Huang YJ, Lin TH, Kuo MC, Shih LY.
    J Hematol Oncol; 2019 Oct 22; 12(1):104. PubMed ID: 31640815
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
    Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O'Keefe C, Hsi ED, List A, Sekeres MA, Rao A, McDevitt MA, Maciejewski JP.
    Blood; 2011 Oct 06; 118(14):3932-41. PubMed ID: 21828135
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.